InvestorsHub Logo
Followers 32
Posts 7648
Boards Moderated 0
Alias Born 10/07/2009

Re: Scragapenny post# 13005

Friday, 01/07/2011 1:12:57 PM

Friday, January 07, 2011 1:12:57 PM

Post# of 54312
And why would HNSS explicitly say that they will not "deal with short sellers through sales of stock".

If is quacks like a duck and walks like a duck, it is probably a duck. There is too much evidence by the company, by the RegSHO data and by the 'fail to deliver' data provided by the SEC to say shorting isn't occuring.

Management's analysis indicates that certain short-term factors have combined to interrupt normal market forces from properly pricing the stock. These factors include:

1. Transitioning of stockholder base in tandem with the Company's new direction and new management into medical manufacturing, consulting, distribution, and online distribution;

2. Year-end tax selling;

3. Short selling and management's refusal to deal with short sellers through sales of stock, etc.;

4. New management's opposition to paid stock promotions which tend to produce stock price peaks and valleys instead of stable increases.

Management strongly believes that its philosophy of concentrating on business fundamentals is the only long-term solution to improving and maintaining a representative stock price.


IMO